Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

BACKGROUND: Breast cancer (BCa) is the leading cause of cancer deaths among women. Reliable biomarkers for early diagnosis and metastasis prediction are essential to improve the prognosis of BCa. This study aimed to evaluate serum periostin (POSTN) as a novel biomarker complementing CA153 (carbohydr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Li, Li, Guanhua, Ma, Na, Zhang, Aimin, Zhou, Yunli, Ren, Li, Dong, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281047/
https://www.ncbi.nlm.nih.gov/pubmed/35831854
http://dx.doi.org/10.1186/s12885-022-09864-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281047/
https://www.ncbi.nlm.nih.gov/pubmed/35831854
http://dx.doi.org/10.1186/s12885-022-09864-y

Ejemplares similares